Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Semaglutide Study Finds Link to Blood Clots A 2021 study published in the Endocrine Journal (Volume 68, Issue 6, pages 739-742) found that type 2 diabetes patients using semaglutide were at a 266% increased risk of deep vein thrombosis
As a GLP-1 receptor agonist, semaglutide mimics the action of the GLP-1 hormone your body produces after food intake
Ongoing Support Patients have access to continued check-ins, progress monitoring, and clinical guidance throughout their program
Diabetes Care 46 , 801810 (2023)
For a patient starting at 200 lbs, this translates to a weight loss of roughly 30 to 32 lbs
US$ 24.75
US$ 29.91
US$ 21.97
US$ 20.79
US$ 26.44
US$ 21.79
